Rosanne Schmachtenberg

Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management

C. Dincer, G. A. Urban, W. Weber, 2022, Materials Today.

A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections

D. Bernstein, A. Burger-Kentischer, T. Grunwald, 2021, Science Translational Medicine.